19 Cathie Wood Beam Therapeutics Trades
Cathie Wood's position in Beam Therapeutics is currently worth $164M. That's 1.20% of their equity portfolio (23rd largest holding). The investor owns 9.91% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares twelve more times and sold shares on six occasions. The investor's estimated purchase price is $573M, resulting in a loss of 71%.
Avg closing price
Price range
Increased shares by 4.3% (+368k shares)
Q2 2025
Avg closing price
$17.40
Price range
$14.54
-
$20.24
Increased shares by 20.0% (+1.41M shares)
Q1 2025
Avg closing price
$26.26
Price range
$19.53
-
$34.09
Increased shares by 8.2% (+537k shares)
Q4 2024
Avg closing price
$25.65
Price range
$21.55
-
$30.35
Sold 14.4% shares (-1.1M shares)
Q3 2024
Avg closing price
$25.81
Price range
$22.57
-
$33.14
Sold 6.8% shares (-556k shares)
Q2 2024
Avg closing price
$24.56
Price range
$21.22
-
$32.66
Sold 12.9% shares (-1.21M shares)
Q1 2024
Avg closing price
$31.16
Price range
$23.46
-
$45.07
Increased shares by 6.9% (+610k shares)
Q4 2023
Avg closing price
$24.84
Price range
$17.69
-
$30.76
Increased shares by 4.8% (+401k shares)
Q3 2023
Avg closing price
$26.81
Price range
$23.01
-
$32.46
Sold 2.2% shares (-191k shares)
Q2 2023
Avg closing price
$32.45
Price range
$29.32
-
$35.99
Increased shares by 4.4% (+360k shares)
Q1 2023
Avg closing price
$39.47
Price range
$30.15
-
$48.79
Sold 3.3% shares (-278k shares)
Q4 2022
Avg closing price
$44.79
Price range
$36.73
-
$51.60
Sold 3.4% shares (-301k shares)
Q3 2022
Avg closing price
$57.05
Price range
$39.79
-
$70.31
Increased shares by 7.2% (+591k shares)
Q2 2022
Avg closing price
$39.75
Price range
$29.86
-
$62.36
Increased shares by 2.7% (+217k shares)
Q1 2022
Avg closing price
$65.59
Price range
$53.73
-
$82.16
Increased shares by 16.7% (+1.14M shares)
Q4 2021
Avg closing price
$85.62
Price range
$68.02
-
$99.06
Increased shares by 5.9% (+380k shares)
Q3 2021
Avg closing price
$100.46
Price range
$84.37
-
$133.60
Increased shares by 35.2% (+1.68M shares)
Q2 2021
Avg closing price
$79.68
Price range
$64.12
-
$128.71
Increased shares by 322.3% (+3.65M shares)
Q1 2021
Avg closing price
$95.13
Price range
$71.28
-
$120.75
New holding (+1.13M shares)
Q4 2020
Avg closing price
$49.18
Price range
$22.24
-
$95.63
News about Beam Therapeutics Inc and Cathie Wood
Cathie Wood''s Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trials
Summary List Placement Cathie Wood''s Ark Invest ETFs surged on Monday following the landmark results of Intellia Therapeutics'' genomic editing clinical tri...